Late Breaking Science: The Role of Nutritional Cognitive Behavioral Therapy (nCBT) In Prescribable Software for Treating Type 2 Diabetes

Attend this 1-hour educational webinar symposium

Wednesday, June 1, 2022
12:00-1:00pm ET/9:00-10:00am PT

This event has ended

This event has concluded. Thank you to all who presented and attended the live event. This symposium is now available on-demand at MedEd On The Go - View this program

Event Overview

Cognitive behavioral therapy delivered by prescription digital therapeutics (PDTs) is granting physicians a new opportunity to treat the root cause of type 2 diabetes to make meaningful, lasting behavioral changes that can lower glycemic levels and limit the progression of the disease. Learn how these new treatments use tried and true methods like nutritional cognitive behavioral therapy to support better health, less reliance on costly medications and fewer adverse events – and why the ADA is including digital therapies in their new Standards of Care.

Program Chair

Marc Bonaca, MD

Director of Vascular Research
Professor of Medicine
University of Colorado School of Medicine
Aurora, CO

Program Moderators

Robert Eckel, MD

Professor of Medicine, Emeritus
Division of Endocrinology, Metabolism,
and Diabetes; Division of Cardiology
University of Colorado Anschutz Medical Campus, Aurora, CO

Judith Hsia, MD

Research Professor of Medicine
University of Colorado
Aurora, CO

Panel & Presenters

Hayden Bosworth, PhD

Research Professor, Department of Population Health Sciences Duke University Medical Center Durham, NC

Amy Bucher, PhD

Chief Behavioral Officer
Lirio
Knoxville, TN

Prapti Mehta, MD

Private Practice Psychiatrist
San Francisco, CA

Kristin Wynholds

Chief Product Officer
Better Therapeutics
San Francisco, CA

Program Objectives

Present revised ADA behavioral therapy guideline recommendations for facilitating behavior change to improve health outcomes in type 2 diabetes
Define the clinical intent and how nCBT works to facilitate behavioral change
Review application of behavioral science and nCBT in prescribable software used in treating type 2 diabetes
Evaluate late breaking trial data assessing the efficacy and safety of prescription digital therapeutics using nutritional CBT
Conduct a multi-disciplinary panel to discuss the potential for prescription digital therapeutics using nutritional CBT to address ADA behavior change guideline gaps and provider needs to improve type 2 diabetes patient outcomes

Agenda

PRESENTATION TITLE

SPEAKER

Introduction and Program Overview

Robert Eckel, MD
Judith Hsia, MD

ADA Recommendations for Facilitating Behavioral Change in Type 2 Diabetes and Remaining Unmet Needs

Hayden Bosworth, PhD

Designing Software for Behavioral Change

Amy Bucher, PhD

nCBT: Clinical Intent, What It Is and How It Works

Prapti Mehta, MD

Application of Behavioral Science and nCBT in a Prescription Digital Therapeutic

Kristin Wynholds

Review of Late Breaking Data Assessing the Efficacy and Safety of Digitally Delivered Nutritional CBT for Patients With Type 2 Diabetes

Marc Bonaca, MD

Panel Discussion Addressing Key Topics:

Behavioral guideline changes and relevance to patients and providers
Interpretation of prescription digital therapeutic clinical compellingness associated with:

Potential for nCBT to address behavioral therapy guideline gaps
Role of behavioral science and nCBT in software used in treating type 2 diabetes
Application of a new, prescribable digital toolkit for clinicians and patients in the treatment of type 2 diabetes

Robert Eckel, MD
Judith Hsia, MD
Marc Bonaca, MD
Amy Bucher, PhD
Hayden Bosworth, PhD
Prapti Mehta, MD
Kristin Wynholds

Summary wrap-up

Robert Eckel, MD
Judith Hsia, MD

This event has ended

This webinar is hosted by the medical education platform MedEd On The Go and supported by an educational grant from Better Therapeutics